AzTrials
AzTrials

Physical ActivityNCT03305172

Structuring Financial Incentives to Increase Physical Activity

A study testing Financial Incentive in people with Physical Activity and Weight Loss, run by National University of Singapore at 1 site in Singapore.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate the effectiveness of different structures of long term financial incentives on increasing physical activity performed by subjects, as measured by the number of steps walked per day. Read more about this study

Who is it for?
Ages 25 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Physical Activity, Weight Loss
What is being tested?
Financial Incentive
Could I receive a placebo?
No, everyone receives an active treatment
How many people
620 participants
Where
1 siteSingapore
Study dates
9 Oct 2017to 30 Jan 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Singapore citizens and permanent residents
  • Adults with BMI greater than 22
  • Ownership of a smartphone or tablet
  • Only one member per household can participate in the study

Who cannot join

  • Women who are pregnant or breast feeding, or who intend to become pregnant over next year
  • Subjects who are already participating in another physical activity program or study
  • Subjects who are unable to participate for a total of 1 year
  • Subjects who are unwilling to wear the fitness device
  • Subjects who already walk more than 10,000 steps a day (self-reported per-day-average over seven days)
  • Subjects who have any of the following health conditions:
Show all 14Show fewer
  • high blood pressure
  • high cholesterol
  • heart attack
  • heart failure
  • stroke
  • chronic obstructive pulmonary disease
  • kidney disease
  • diabetes (type 2)

Trial locations and contacts

1 site in 1 country.

Singapore1 site
  • National University of Singapore

    Singapore, 119077

Other trials in Singapore

About this study

The purpose of this study is to evaluate the effectiveness of different structures of long term financial incentives on increasing physical activity performed by subjects, as measured by the number of steps walked per day.

Investigators are interested in studying whether physical activity increases during an intervention period (with incentives) and a post-intervention period (with no incentives).

Read the detailed description

The proposed study is a field experiment. Adults within the ages of 25 and 60 years of age, and with a body mass index of 22 or higher will be eligible to participate.

The study will consist of (1) a two-week baseline period, (2) a 36-week intervention period, and (3) a 12-week follow-up period.

At the beginning of the study, subjects will be given a wearable fitness device and their daily step count will be monitored for two weeks; this is the baseline period. After the two-week baseline period, the subjects will be randomly assigned to one of the five different conditions (Control, Gain, Loss, Gain Streak, or Loss Streak) and will be given the goal to increase their baseline step counts by 2,500 steps.

=====

HYPOTHESES -- Investigators expect the following:

  1. Loss Aversion: Subjects in the Loss treatment will achieve the goal on a greater number of days than subjects in the Gain treatment.
  2. Streak: Subjects in the Gain treatment will achieve the goal on a greater number of days than subjects in the Gain Streak treatment.
  3. Loss Streak: Subjects in the Loss treatment will achieve the goal on a greater number of days than subjects in the Loss Streak treatment. Whether subjects in the Loss Streak treatment will perform better or worse than subjects in the other two treatments will be investigated.

CONTRIBUTION -- Prior research has not examined the effect of a long term financial incentive (36 weeks) on individual behavior in achieving a goal. In this study, the investigators also examine two additional financial incentive structures: Gain Streak and Loss Streak. If the hypotheses are correct, the results have important implications for designing financial incentives to encourage good behavior and to encourage good habit formation across domains.

Being tested
Financial Incentive
Medical subject headings
Motor Activity, Weight Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Financial IncentiveBehavioural

    Giving different structures of long term (36 weeks) financial incentives to increase physical activity

Study groups in NCT03305172
Study groupRoleWhat they receive
ControlNo interventionSubjects in the Control treatment are not given any financial incentive to achieve the goal.
Gain TreatmentExperimentalFinancial Incentive: Each subject in the Gain treatment will earn a certain amount of money for each day the goal is achieved. The money earned will be added to a virtual account that the subject has, and will be paid to the subject at the end of the intervention period.
Receives: Behavioral: Financial Incentive
Loss TreatmentExperimentalFinancial Incentive: Each subject in the Loss treatment will be given a certain amount of money in his/her virtual account at the beginning of every week. For each day that the subject does not achieve the goal, a small portion of that money will be deducted from the virtual account. The balance that is left in the virtual account will be paid to the subject at the end of the intervention period.
Receives: Behavioral: Financial Incentive
Gain Streak TreatmentExperimentalFinancial Incentive: Each subject in the Gain Streak treatment get an increasing amount of money added to his/her virtual account for every continuous day that they achieve the goal. The maximum cumulative amount per week is same as in the other treatment conditions. The payment is reset at the beginning of each week, or if the subject misses the goal on any day. The money in the virtual account will be paid to the subject at the end of the intervention period.
Receives: Behavioral: Financial Incentive
Loss Streak TreatmentExperimentalFinancial Incentive: Each subject in the Loss Streak treatment will be given a certain amount of money in his/her virtual account at the beginning of every week. An increasing amount of money will be deducted for each consecutive day the subject does not achieve the goal. The payment is reset at the beginning of each week, or when the subject achieves the goal (i.e., deductions are reset when the streak is broken). The balance that is left in the virtual account will be paid to the subject at the end of the intervention period.
Receives: Behavioral: Financial Incentive

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Step count goal -- Intervention

    Proportion of participant-days on which the goal (baseline +2,500 steps) was achieved during the intervention period.

    Measured: 36-week intervention period following the baseline period.

  2. Change in mean daily steps -- Intervention

    Change in mean daily steps during the intervention period.

    Measured: 36-week intervention period following the baseline period.

Secondary outcomes (8)
  1. Step count goal -- Post-intervention

    Proportion of participant-days on which the goal (baseline +2,500 steps) was achieved during the post-intervention period.

    Measured: 12-week post-intervention period.

  2. Change in mean daily steps -- Post-intervention

    Change in mean daily steps during the post-intervention period.

    Measured: 12-week post-intervention period.

  3. Sleep Pattern -- Intervention

    Changes in sleep pattern (deep sleep, hours of continuous sleep) during the intervention period.

    Measured: 36-week intervention period following the baseline period.

  4. Sleep Pattern -- Post-intervention

    Changes in sleep pattern (deep sleep, hours of continuous sleep) during the post-intervention period.

    Measured: 12-week post-intervention period.

  5. Weight (in kilograms) Loss -- Intervention

    Drop in weight from baseline to the end of the intervention period.

    Measured: 36-week intervention period following the baseline period.

  6. Weight (in kilograms) Loss -- Post-intervention

    Drop in weight from baseline to the end of the post-intervention period.

    Measured: 48-week period following the baseline period.

  7. Change in Waist Measurement (in inches) -- Intervention

    Change in waist measurements from baseline to the end of the intervention period.

    Measured: 36-week intervention period following the baseline period

  8. Change in Waist Measurement (in inches) -- Post-intervention

    Change in waist measurements from baseline to the end of the post-intervention period.

    Measured: 48-week period following the baseline period.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Oct 2017
  2. Study start9 Oct 2017
  3. Primary completion17 Jan 2019
  4. Study completion30 Jan 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
620 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03305172
Sponsor's protocol ID
SG-STEP
Status last verified
Oct 2019
First submitted
26 Sep 2017
Last updated
4 Oct 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Investigators will not be storing or sharing any personal identifiers. All individual level data will be anonymized, and only anonymized data will be shared with other researchers, upon request.

Questions about this trial

What is this clinical trial studying?

A study testing Financial Incentive in people with Physical Activity and Weight Loss, run by National University of Singapore at 1 site in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Oct 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Step count goal -- Intervention (time frame: 36-week intervention period following the baseline period.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Oct 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in